Shijiazhuang Yiling Pharmaceutical Stock Current Valuation
| 002603 Stock | 17.03 0.12 0.71% |
Valuation analysis of Shijiazhuang Yiling helps investors to measure Shijiazhuang Yiling's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Shijiazhuang Yiling's Cash is projected to increase significantly based on the last few years of reporting. The current year's End Period Cash Flow is expected to grow to about 1.1 B, whereas Other Cashflows From Financing Activities is forecasted to decline to about 1 M. Fundamental drivers impacting Shijiazhuang Yiling's valuation include:
Price Book 2.4558 | Enterprise Value 28.7 B | Enterprise Value Ebitda 98.1282 | Price Sales 3.5149 | Trailing PE 189.2222 |
Overvalued
Today
Please note that Shijiazhuang Yiling's price fluctuation is not too volatile at this time. Calculation of the real value of Shijiazhuang Yiling is based on 3 months time horizon. Increasing Shijiazhuang Yiling's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Shijiazhuang Yiling is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Shijiazhuang Stock. However, Shijiazhuang Yiling's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.03 | Real 14.09 | Hype 16.89 | Naive 16.56 |
The real value of Shijiazhuang Stock, also known as its intrinsic value, is the underlying worth of Shijiazhuang Yiling Company, which is reflected in its stock price. It is based on Shijiazhuang Yiling's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Shijiazhuang Yiling's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Shijiazhuang Yiling Pharmaceutical helps investors to forecast how Shijiazhuang stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Shijiazhuang Yiling more accurately as focusing exclusively on Shijiazhuang Yiling's fundamentals will not take into account other important factors: Shijiazhuang Yiling Pharmaceutical Company Current Valuation Analysis
Shijiazhuang Yiling's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Shijiazhuang Yiling Current Valuation | 28.68 B |
Most of Shijiazhuang Yiling's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Shijiazhuang Yiling Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Shijiazhuang Yiling Pharmaceutical has a Current Valuation of 28.68 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Shijiazhuang Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Shijiazhuang Yiling's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Shijiazhuang Yiling could also be used in its relative valuation, which is a method of valuing Shijiazhuang Yiling by comparing valuation metrics of similar companies.Shijiazhuang Yiling is currently under evaluation in current valuation category among its peers.
Shijiazhuang Fundamentals
| Return On Equity | 0.012 | ||||
| Return On Asset | 0.0055 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 28.68 B | ||||
| Shares Outstanding | 1.67 B | ||||
| Shares Owned By Insiders | 57.39 % | ||||
| Shares Owned By Institutions | 4.50 % | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 3.51 X | ||||
| Revenue | 10.32 B | ||||
| Gross Profit | 6.42 B | ||||
| EBITDA | 764.15 M | ||||
| Net Income | 1.35 B | ||||
| Total Debt | 600.35 M | ||||
| Book Value Per Share | 6.89 X | ||||
| Cash Flow From Operations | 155.46 M | ||||
| Earnings Per Share | 0.09 X | ||||
| Target Price | 20.95 | ||||
| Number Of Employees | 13.96 K | ||||
| Beta | 0.22 | ||||
| Market Capitalization | 28.5 B | ||||
| Total Asset | 16.98 B | ||||
| Retained Earnings | 6.51 B | ||||
| Working Capital | 2.1 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 16.98 B | ||||
| Last Dividend Paid | 0.3 |
About Shijiazhuang Yiling Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Shijiazhuang Yiling Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Shijiazhuang Yiling using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Shijiazhuang Yiling Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Shijiazhuang Stock
Shijiazhuang Yiling financial ratios help investors to determine whether Shijiazhuang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shijiazhuang with respect to the benefits of owning Shijiazhuang Yiling security.